🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines
Updated 04 Jul 2026 · HPRA open data

Fresenius Kabi Deutschland GmbH — Licensed Medicines

164 medicines held by Fresenius Kabi Deutschland GmbH on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 164 products held by Fresenius Kabi Deutschland GmbH
MedicineActive substanceLicence holderStatus
Glucose 5% w/v Solution for Infusion
PA2059/040/001
Glucose anhydrous Fresenius Kabi Deutschland GmbH Not marketed
Glucose 5% w/v Solution for Infusion
PA2059/040/003
Glucose anhydrous Fresenius Kabi Deutschland GmbH Not marketed
Glucose 5% w/v Solution for Infusion
PA2059/040/004
Glucose anhydrous Fresenius Kabi Deutschland GmbH Marketed
Glucose 5% w/v Solution for Infusion
PA2059/040/009
Glucose anhydrous Fresenius Kabi Deutschland GmbH Marketed
Glucose 5% w/v, Solution for Infusion
PA2059/040/002
Glucose anhydrous Fresenius Kabi Deutschland GmbH Not marketed
Hartmann's Solution for Infusion, PE bottle
PA2059/057/005
Sodium chloride, Potassium chloride, Calcium chloride dihydrate, Sodium lactate Fresenius Kabi Deutschland GmbH Not marketed
Hartmann’s Solution for Infusion, glass bottle
PA2059/057/004
Sodium chloride, Potassium chloride, Calciumchloride dihydrate, Sodium lactate Fresenius Kabi Deutschland GmbH Not marketed
Hartmann’s Solution for Infusion, PPC PSEB bag
PA2059/057/003
Sodium chloride, Potassium chloride, Calcium chloride dihydrate, Sodium lactate Fresenius Kabi Deutschland GmbH Marketed
Hartmann’s Solution for Infusion, PSEB bag
PA2059/057/002
Sodium chloride, Potassium chloride, Calcium chloride dihydrate, Sodium lactate Fresenius Kabi Deutschland GmbH Not marketed
Hartmann’s Solution for Infusion, PVC bag
PA2059/057/001
Sodium chloride, Potassium chloride, Calcium chloride dihydrate, Sodium lactate Fresenius Kabi Deutschland GmbH Not marketed
IDACIO 40 mg Solution for injection
EU/1/19/1356/002
Adalimumab Fresenius Kabi Deutschland GmbH
IDACIO 40 mg Solution for injection
EU/1/19/1356/003
Adalimumab Fresenius Kabi Deutschland GmbH
IDACIO 40 mg/0.8 ml Solution for injection
EU/1/19/1356/001
Adalimumab Fresenius Kabi Deutschland GmbH
Imipenem/Cilastatin 250 mg/250 mg powder for solution for infusion
PA2059/074/001
Imipenem, Cilastatin Fresenius Kabi Deutschland GmbH Not marketed
Imipenem/Cilastatin 500 mg/500 mg powder for solution for infusion
PA2059/074/002
Imipenem, Cilastatin Fresenius Kabi Deutschland GmbH Marketed
Infutraze concentrate for solution for infusion
PA2059/083/001
Copper chloride dihydrate, Manganese chloride tetrahydrate, Potassium iodide, Sodium selenite anhydrous, Zinc chloride Fresenius Kabi Deutschland GmbH Not marketed
Intralipid 20% w/v Emulsion for Infusion Biofine bag
PA2059/041/005
Soya bean oil, refined Fresenius Kabi Deutschland GmbH Marketed
Intralipid 20% w/v Emulsion for Infusion, Glass Bottle
PA2059/041/001
Soya bean oil Fresenius Kabi Deutschland GmbH Not marketed
Ionolyte solution for infusion
PA2059/042/001
Sodium acetate trihydrate, Sodium chloride, Potassium chloride, Magnesium chloride hexahydrate, Sodium hydroxide Fresenius Kabi Deutschland GmbH Not marketed
Irinotecan 20 mg/ml Concentrate for solution for infusion
PA2059/044/001
Irinotecan hydrochloride trihydrate Fresenius Kabi Deutschland GmbH Marketed
Kabiven emulsion for infusion
PA2059/045/003
Soya bean oil, Glucose monohydrate, Alanine, Arginine, Aspartic Acid Fresenius Kabi Deutschland GmbH Marketed
Kabiven Peripheral emulsion for infusion
PA2059/045/004
Soya bean oil, Alanine, Aspartic Acid, Glutamic acid, Glycine Fresenius Kabi Deutschland GmbH Marketed
Lacosamide Fresenius Kabi 10 mg/ml solution for infusion
PA2059/078/001
Lacosamide Fresenius Kabi Deutschland GmbH Not marketed
Levetiracetam Kabi 10 mg/ml solution for infusion
PA2059/088/002
Levetiracetam Fresenius Kabi Deutschland GmbH Not marketed
Levetiracetam Kabi 5 mg/ml solution for infusion
PA2059/088/001
Levetiracetam Fresenius Kabi Deutschland GmbH Not marketed
Levobupivacaine 0.625 mg/ml solution for infusion
PA2059/009/001
Levobupivacaine Fresenius Kabi Deutschland GmbH Marketed
Levobupivacaine 1.25 mg/mL solution for infusion
PA2059/009/002
Levobupivacaine Fresenius Kabi Deutschland GmbH Marketed
Levobupivacaine 2.5 mg/mL solution for injection/infusion
PA2059/009/003
Levobupivacaine Fresenius Kabi Deutschland GmbH Marketed
Levobupivacaine 5.0 mg/mL solution for injection/infusion
PA2059/009/004
Levobupivacaine Fresenius Kabi Deutschland GmbH Marketed
Levobupivacaine 7.5 mg/mL solution for injection/infusion
PA2059/009/005
Levobupivacaine Fresenius Kabi Deutschland GmbH Marketed
Levofloxacin 5 mg/ml solution for infusion, freeflex bags
PA2059/010/002
Levofloxacin Fresenius Kabi Deutschland GmbH Not marketed
Levofloxacin 5 mg/ml solution for infusion, LDPE bottles
PA2059/010/001
Levofloxacin Fresenius Kabi Deutschland GmbH Marketed
Lidocaine Hydrochloride 1% w/v Solution for Injection
PA2059/003/001
Lidocaine Hydrochloride Monohydrate Fresenius Kabi Deutschland GmbH Marketed
Lidocaine Hydrochloride 2% w/v Solution for Injection
PA2059/003/002
Lidocaine Hydrochloride Monohydrate Fresenius Kabi Deutschland GmbH Marketed
Linezolid 2 mg/ml solution for infusion
PA2059/011/001
Linezolid Fresenius Kabi Deutschland GmbH Marketed
Meropenem 1 g powder for solution for injection or infusion
PA2059/012/002
Meropenem Trihydrate Fresenius Kabi Deutschland GmbH Marketed
Meropenem 500 mg powder for solution for injection or infusion
PA2059/012/001
Meropenem Trihydrate Fresenius Kabi Deutschland GmbH Marketed
Moxifloxacin 400 mg/250 ml Solution for Infusion, FreeFlex bags
PA2059/013/002
Moxifloxacin Fresenius Kabi Deutschland GmbH Not marketed
Moxifloxacin 400 mg/250 ml Solution for Infusion, KabiPac bottles
PA2059/013/001
Moxifloxacin Fresenius Kabi Deutschland GmbH Not marketed
Noradrenaline (Norepinephrine) Kabi 1 mg/ml concentrate for solution for infusion
PA2059/073/001
Sodium chloride, Noradrenaline tartrate Fresenius Kabi Deutschland GmbH Marketed
Ondansetron Kabi 0.08 mg/ml solution for infusion
PA2059/080/001
Ondansetron hydrochloride dihydrate Fresenius Kabi Deutschland GmbH Not marketed
Ondansetron Kabi 0.16 mg/ml solution for infusion
PA2059/080/002
Ondansetron hydrochloride dihydrate Fresenius Kabi Deutschland GmbH Not marketed
Ondansetron Kabi 2 mg/ml solution for injection
PA2059/048/001
Ondansetron Fresenius Kabi Deutschland GmbH Marketed
Otulfi 130 mg Concentrate for solution for infusion
EU/1/24/1863/003
Ustekinumab Fresenius Kabi Deutschland GmbH
Otulfi 45 mg Solution for injection
EU/1/24/1863/001
Ustekinumab Fresenius Kabi Deutschland GmbH
Otulfi 45 mg Solution for injection pre-filled pen
EU/1/24/1863/005
Ustekinumab Fresenius Kabi Deutschland GmbH
Otulfi 90 mg Solution for injection
EU/1/24/1863/002
Ustekinumab Fresenius Kabi Deutschland GmbH
Otulfi 90 mg Solution for injection in Pre-filled pen
EU/1/24/1863/006
Ustekinumab Fresenius Kabi Deutschland GmbH
Oxaliplatin 5 mg/ml concentrate for solution for infusion
PA2059/049/001
Oxaliplatin Fresenius Kabi Deutschland GmbH Marketed
Paclitaxel 6 mg/ml concentrate for solution for infusion
PA2059/050/001
Paclitaxel Fresenius Kabi Deutschland GmbH Marketed
1 2 3 4
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 20 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.